US FDA – Page 59 – Express Pharma

30 Per cent of ANDAs approved by the US FDA in the year 2016 are from India

Sun Pharma ties up with Samsung BioLogics

Unichem gets EIR from US FDA for Goa plant

Zydus Cadila gets US FDA nod to market anti-obesity drug

Zydus Cadila to market oxybutynin chloride tablets

Glenmark Pharma receives tentative ANDA approval for solifenacin succinate tabs

FDA publishes draft guidance on assessing adhesion with TDS and topical patches for ANDAs

Claris announces receipt of EIR from US FDA

Lupin announces closure of US FDA audits for its Mandideep and Aurangabad facilities

Indoco Remedies receives US FDA nod for Goa manufacturing facility